Tapan M. Kadia, MD

Tapan M. Kadia, MDAssociate Professor
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

Dr. Tapan Kadia received his medical degree from Robert Wood Johnson Medical School in Piscataway, New Jersey. He completed his clinical internship, clinical residency, and chief residency at Baylor College of Medicine Affiliated Hospitals in Houston, Texas. In addition, he completed a clinical fellowship in hematology/oncology at The University of Texas MD Anderson Cancer Center in Houston, Texas. Dr. Kadia is currently an Associate Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center where he is actively involved in clinical and translational research for the treatment of patients with leukemia.

Dr. Kadia’s primary focus is in developmental therapeutics in acute leukemia, including individualized frontline therapy, biologically rational targeted therapy, and longer term maintenance strategies in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). He is primary investigator on numerous trials in AML, T-cell leukemias, and bone marrow failure states. Dr. Kadia has authored more than160 peer-reviewed articles, numerous abstracts, and has been invited nationally and internationally for presentation of his research. He has received numerous academic and clinical honors and awards for his studies and clinical research.

Last modified: April 12, 2022